Two researchers at PNNL have been named fellows of the American Chemical Society: Karthikeyan Ramasamy and Yuyan Shao.

PNNL has named Biomedical Scientist Tom Metz, an expert on metabolomics and multi-omics within the Biological Sciences Division, a 2023 Laboratory Fellow.

Small teams in the Biological Sciences Division at PNNL and at EMSL—the Environmental and Molecular Sciences Laboratory, an Office of Science user facility at PNNL—are pros at preparation.

Scientists have taken an important step forward in predicting who will develop Type 1 diabetes months before symptoms appear.

Joshua Adkins and Jamie Lo will lead PMedIC, Pacific Northwest National Laboratory and Oregon Health & Science University’s joint research institute.

PNNL scientists are creating new ways to learn more about the vast sea of chemicals that haven't been identified—yet.

DOE gives Hydrogen Program Special Award to PNNL's Hydrogen Safety Panel at department's 2023 Annual Merit Review and Peer Evaluation Meeting.

PNNL scientists investigate the promising properties of a common, Earth-abundant salt.

Metabolomics analysis revealed differences in metabolome profiles for two distinct modes of fungal wood decay.

Methods review suggests ways to use artificial intelligence and machine learning to handle missing data when integrating two or more omics approaches.

PNNL chemist Christopher Anderton recently named president-elect of the Imaging Mass Spectrometry Society (IMSS). In this new position, he will help lead the merge of IMSS with a European-based society, currently underway.

PNNL hydrogen expert Olga Marina has been named among the pioneering women in applied physics in a roadmap published in Journal of Physics D.

Patented microchannel heat-exchange technology enables the production of hydrogen from methane, the main ingredient of natural gas, while producing 30 percent less carbon dioxide than conventional processes.

PNNL is working with the Port of Seattle and Seattle City Light to assess the risks of long-term hydrogen storage that can bring clean power for decarbonization.

Data-driven autonomous technology to rapidly design and deliver antiviral interventions targeting SARS-CoV-2 to reduce drug discovery timeline and advance bio preparedness capabilities.

Exploring why some brains are more resilient to the impact of Alzheimer’s disease could lead to improved diagnoses, treatment and prevention.

Advanced proteomic analysis tools dig deep into human blood plasma to understand the molecular nature of advanced alcoholic disease.

A detailed snapshot of proteins by PNNL scientists marks a big step toward a diagnostic blood test for a deadly form of liver disease.

Harnessing the sea for decarbonized energy is the focus of a new collaboration between PNNL and the University of Guam.

Findings show method to better prepare human lung tissue for study; it represents the latest mass spectrometry-based omics advances.